Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 2 Results

Intervention Indication Therapeutic Area Year Actions
Treosulfan in combination with Fludarabine for Malignant and Non-Malignant diseases - prior to stem cell transplantation Fludarabine (fludarabine phosphate) , Treosulfan (Ovastat) Acute myeloid leukaemia (AML) , Myelodysplastic syndrome (MDS) Haematological Cancer and Lymphomas 2018 View  |  Download
Treosulfan in combination with fludarabine for paediatric non-malignant disease before allogeneic stem cell transplant Fludarabine (fludarabine phosphate) , Treosulfan (Ovastat) Non-malignant diseases Endocrine Nutritional and Metabolic Disorders , Haematology , Immunology 2019 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications